Tag Archives: Kari Sorland

Intravenous cyclophosphamide in ME/CFS. An open-label phase II study

Intravenous Cyclophosphamide in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. An Open-Label Phase II Study by Ingrid G Rekeland, Alexander Fosså, Asgeir Lande, Irini Ktoridou-Valen, Kari Sørland, Mari Holsen, Karl J Tronstad, Kristin Risa, Kine Alme, Marte K Viken, Benedicte A Lie, Olav … Continue reading

Posted in News | Tagged , , , , , , , , , , , , , , , , , | Comments Off on Intravenous cyclophosphamide in ME/CFS. An open-label phase II study

Searching for serum antibodies to neuronal proteins in patients with ME/CFS

Searching for serum antibodies to neuronal proteins in patients with Myalgic Encephalopathy/Chronic Fatigue Syndrome, by Maria Pia Giannoccaro, Judith Cossins, Kari Sorland, Oystein Fluge, Angela Vincent in Clinical Therapeutics Vol 41, Issue 5, May 2019, Pages 836-847   Research abstract: Purpose: … Continue reading

Posted in News | Tagged , , , , , , , , | Comments Off on Searching for serum antibodies to neuronal proteins in patients with ME/CFS

Video lectures from English & Norwegian researchers in Norwich

Invest in ME public talks in Norwich on ME/CFS biomedical research, published 7 Feb 2017 An event held in Norwich in January 2017 gave the public a chance to hear about some of the biomedical research being undertaken on the … Continue reading

Posted in News | Tagged , , , , , | Comments Off on Video lectures from English & Norwegian researchers in Norwich